21 CFR 522.930

§ 522.930 Firocoxib.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 522.930, § 522.930 Firocoxib, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87437
Permanent ID: ys:prov:87437@1
SHA-256: f5ebffb165fdd1aa96dcb995f2421af8fca522001c284ed15e565397ba4226a3

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each milliliter of solution contains 20 milligrams (mg) firocoxib. (b) Sponsors. See No. 000010 in § 510.600(c) of this chapter. (c) Conditions of use in horses—(1) Amount. Administer 0.04 mg/pound (lb) (0.09 mg/kilogram (kg)) of body weight (BW) intravenously, once daily, for up to 5 days. If further treatment is needed, firocoxib oral paste can be administered at a dosage of 0.045 mg/lb (0.1 mg/kg) of BW for up to an additional 9 days of treatment. (2) Indications for use. For the control of pain and inflammation associated with osteoarthritis. (3) Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.